Related Experiment Videos
Prostacyclin-stimulating factor, novel protein, and diabetic angiopathy
1Third Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Diabetes
|July 1, 1996
Summary
A newly discovered protein, prostacyclin (PGI2)-stimulating factor (PSF), is present in various rat and human tissues. Reduced PSF expression in diabetic rat kidneys and atherosclerotic human arteries suggests its role in vascular health.
Area of Science:
- Vascular Biology
- Molecular Biology
- Biochemistry
Background:
- Prostacyclin (PGI2) is crucial for vascular homeostasis.
- The protein regulating PGI2 synthesis in vascular endothelial cells (ECs) was previously unknown.
- A novel protein, PGI2-stimulating factor (PSF), has been identified.
Purpose of the Study:
- To investigate the expression and localization of PSF in various tissues.
- To assess PSF levels in diabetic and atherosclerotic conditions.
- To explore the potential role of PSF in vascular health and disease.
Main Methods:
- Northern blot analysis for PSF mRNA expression in rat tissues and cultured cells.
- Western blot analysis for PSF presence in human serum.
- Immunohistochemical localization of PSF in human autopsy tissues.
Main Results:
- PSF mRNA was detected in all examined rat tissues and cultured vascular ECs, smooth muscle cells (SMCs), and fibroblast cells (FCs).
- Kidney PSF expression was decreased in diabetic rats compared to normal rats.
- PSF was localized in human vascular ECs, arterial SMCs, and bronchial SMCs, with reduced staining in atherosclerotic coronary arteries.
Conclusions:
- PSF is expressed in multiple rat and human tissues, particularly in vascular cells.
- Decreased PSF expression correlates with diabetic and atherosclerotic conditions.
- PSF may play a significant role in maintaining vascular homeostasis and its dysregulation may contribute to vascular pathologies.